These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11399244)

  • 1. Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass.
    Lango R; Smolenski RT; Narkiewicz M; Suchorzewska J; Lysiak-Szydlowska W
    Cardiovasc Res; 2001 Jul; 51(1):21-9. PubMed ID: 11399244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of propranolol and diltiazem on carnitine derivatives and acyl CoA in ischemic myocardium.
    Kamiya J; Kobayashi A; Yamazaki N
    Jpn Circ J; 1985 Nov; 49(11):1167-74. PubMed ID: 4094037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic preconditioning and long-chain acyl carnitine in the canine heart.
    Simkhovich BZ; Hale SL; Ovize M; Przyklenk K; Kloner RA
    Coron Artery Dis; 1993 Apr; 4(4):387-92. PubMed ID: 8261212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of metabolic therapy in myocardial infarct].
    Di Biase M; Biasco G; Rizzon P
    Cardiologia; 1991 Dec; 36(12 Suppl 1):389-92. PubMed ID: 1841795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting effects of propionate and propionyl-L-carnitine on energy-linked processes in ischemic hearts.
    Di Lisa F; Menabò R; Barbato R; Siliprandi N
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H455-61. PubMed ID: 8067396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine.
    El Alaoui-Talibi Z; Guendouz A; Moravec M; Moravec J
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H1615-24. PubMed ID: 9139943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart.
    Kobayashi A; Watanabe H; Yamazaki N
    Jpn Heart J; 1988 Nov; 29(6):831-40. PubMed ID: 3241336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-carnitine on the cellular distribution of carnitine and its acyl derivatives in the ischemic heart.
    Fujisawa S; Kobayashi A; Hironaka Y; Yamazaki N
    Jpn Heart J; 1992 Sep; 33(5):693-705. PubMed ID: 1289599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of L-carnitine on ischemic heart disease: experimental results].
    Lerch R
    Praxis (Bern 1994); 1998 Jan; 87(4):97-100. PubMed ID: 9522638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of carbohydrate metabolism in ischemia and reperfusion.
    Lopaschuk G
    Am Heart J; 2000 Feb; 139(2 Pt 3):S115-9. PubMed ID: 10650324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnitine and its role in cardiovascular disease.
    Retter AS
    Heart Dis; 1999; 1(2):108-13. PubMed ID: 11720611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-carnitine on tissue levels of free fatty acid, acyl CoA, and acylcarnitine in ischemic heart.
    Suzuki Y; Kamikawa T; Kobayashi A; Yamazaki N
    Adv Myocardiol; 1983; 4():549-57. PubMed ID: 6856980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients.
    Lango R; Smoleński RT; Rogowski J; Siebert J; Wujtewicz M; Słomińska EM; Lysiak-Szydłowska W; Yacoub MH
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):267-75. PubMed ID: 16187006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical derangements in ischemic myocardium: the role of carnitine.
    Siliprandi N; Di Lisa F; Toninello A
    G Ital Cardiol; 1984 Oct; 14(10):804-8. PubMed ID: 6240423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. l-Carnitine and heart disease.
    Wang ZY; Liu YY; Liu GH; Lu HB; Mao CY
    Life Sci; 2018 Feb; 194():88-97. PubMed ID: 29241711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acylcarnitine accumulation does not correlate with reperfusion recovery in palmitate-perfused rat hearts.
    Madden MC; Wołkowicz PE; Pohost GM; McMillin JB; Pike MM
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2505-12. PubMed ID: 7611501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [L-propionylcarnitine taurine amide induces the metabolic recovery of the isolated postischemic rat heart].
    Lazzarino G; Corsico N; Tavazzi B; di Pierro D; Arrigoni-Martelli E; Giardina B
    Cardiologia; 1992 Oct; 37(10):715-7. PubMed ID: 1296879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of preoperative L-carnitine supplementation on myocardial metabolism during aorto-coronary bypass surgery.
    Böhles H; Noppeney T; Akcetin Z; Rein J; von der Emde J
    Z Kardiol; 1987; 76 Suppl 5():14-8. PubMed ID: 3501644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of metabolically active drugs in the management of ischemic heart disease.
    Schofield RS; Hill JA
    Am J Cardiovasc Drugs; 2001; 1(1):23-35. PubMed ID: 14728049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.